Sponsor Pipeline

Huabo Biopharm Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
4
Disease Areas
Active Trials by Phase
Phase 2
2
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06592274 A Phase 2 Study of HB0017 in Psoriasis Patients Psoriasis (PsO) Recruiting
NCT07376629 A Study of HB0025 Plus Nab-paclitaxel as First Line Therapy for TNBC TNBC Enrolling by Invitation
Phase 1/2
NCT06758557 A Study to Evaluate the Safety and Efficacy of HB0025 Injection in Patients With Advanced… Advanced NSCLC Recruiting
Disease Areas
Psoriasis (1) Non-Small Cell Lung Cancer (NSCLC) (1) Endometrial Cancer (1) Triple-Negative Breast Cancer (1)
Get alerts when Huabo Biopharm Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free